Cannabis Group Series | DEA Final Order: Marijuana Rescheduled Schedule I to Schedule III

On April 23rd, the DEA issued a final order moving certain marijuana classifications from Schedule I to Schedule III of the Controlled Substances Act (CSA). This installment of the Cannabis Video Series, “DEA Final Order: Marijuana Rescheduled Schedule I to Schedule III”, examined this order and the vast impacts that it can and will have on the cannabis industry. Host Craig Small, Co-Chair of Clark Hill’s Cannabis Industry Group, sits down with Karl Frederic, Member at Clark Hill, to discuss this latest evolution in the industry. Together, they analyze the DEA’s final order on marijuana rescheduling and its effects on federal policy, business operations, and market dynamics. Marijuana operators should equip themselves with knowledge about how this momentous shift affects operators, legal requirements, and the push towards federal legalization.

The Historical Context of Cannabis Prohibition

In addition to being an impactful administrative adjustment, the rescheduling of marijuana also represents a historical turning point dating back to the end of alcohol prohibition in the early 20th century. Just as prohibition didn’t stop alcohol consumption, cannabis prohibition failed to halt cannabis usage or the proliferation of related strains and techniques. This backdrop of social change, economic demand, and regulatory complexity underscores the reasons behind the DEA’s most recent order.

What the Order Does — and Doesn’t Do

It’s crucial to clarify what this DEA order actually does. While marijuana’s placement as a Schedule III drug signifies a substantial loosening of restrictions, it doesn’t mean marijuana is now federally legal across the board. The order specifically legalizes state-regulated medical marijuana operators within a tightly defined framework. Recreational marijuana remains illegal on a federal level and is not affected by this rescheduling.

Moreover, there’s an important distinction in terminology. Although the term “marijuana” carries historic and racial connotations, it’s used here in legal contexts to align with federal and state regulations. This order also does not impact the burgeoning hemp industry governed under the 2018 Farm Bill, a separate sphere altogether.

Implications for Operators

For state-licensed medical marijuana operators, this order opens a federally recognized path to legality, which is significant given the historical industry struggles with compliance and prohibition. The rescheduled status essentially allows these operators to pursue DEA registrations, lifting some previously imposed hurdles, particularly concerning gross revenue taxations under Section 280E. This is expected to radically shift the financial dynamics for those in the industry able to capitalize on these new legal standings.

Future and Remaining Challenges

Despite the landmark shift, many aspects remain unresolved. Chief among these are how the Food and Drug Administration (FDA) will integrate into these new rules and whether interstate commerce involving cannabis will become feasible. There are also lingering concerns surrounding clarity on labeling, packaging, and other operational specifics driven by federal oversight.

As Craig and Karl highlighted, the industry’s regulatory journey is far from over. The upcoming hearing on June 29 is set to further define and operationalize this change, providing stakeholders an opportunity to voice their thoughts and influence final implementations. Stakeholders should be prepared to engage constructively in these discussions.

Conclusion: A New Chapter

The DEA’s decision is the beginning of a new chapter for cannabis in America. It offers fresh opportunities but also requires careful navigation of new legal and commercial waters. Those in the industry should engage with their economic and legal advisors to fully understand and leverage these changes. Clark Hill’s Cannabis Industry Group stands ready to help our clients navigate this dynamic and evolving landscape, ensuring they remain compliant while taking full advantage of the new regulatory environment.

For further insights into hemp and cannabis-related discussions, Clark Hill will continue this video series, offering unique opinions for cannabis industry players from Clark Hill attorneys and other industry contributors.

This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services. The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel. The views and opinions expressed herein represent those of the individual author only and are not necessarily the views of Clark Hill PLC. Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness.